Bankura Sammilani Medical College   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Bankura India (1956)

Organization Overview

First Clinical Trial
2008
NCT00680940
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Dermatologic Unit, Ospedale Maggiore Policlinico, Milan, Italy | Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via F. Sforza 28 20122, Milano. | Fondazione per la Ricerca Ospedale Maggiore di Bergamo (FROM) | IRCCS Ca' Granda Ospedale Maggiore Policlinico | IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico | IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico Milano | Ospedale Maggiore di Bergamo | Ospedale Maggiore Policlinico

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia, Hemolytic (Phase 2)

Anemia, Hemolytic, Autoimmune (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Graves Disease (Phase 2)

Graves Ophthalmopathy (Phase 2)

Hemolysis (Phase 2)

Hemophilia A (Phase 4)

Lung Neoplasms (Phase 2)

Polycythemia (Phase 2)

Polycythemia Vera (Phase 2)

Sarcoma (Phase 2)

Sarcoma, Kaposi (Phase 2)

Supranuclear Palsy, Progressive (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 14